267 related articles for article (PubMed ID: 18519758)
1. Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.
Hamada A; Sissung T; Price DK; Danesi R; Chau CH; Sharifi N; Venzon D; Maeda K; Nagao K; Sparreboom A; Mitsuya H; Dahut WL; Figg WD
Clin Cancer Res; 2008 Jun; 14(11):3312-8. PubMed ID: 18519758
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).
Letschert K; Keppler D; König J
Pharmacogenetics; 2004 Jul; 14(7):441-52. PubMed ID: 15226676
[TBL] [Abstract][Full Text] [Related]
3. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
Yang M; Xie W; Mostaghel E; Nakabayashi M; Werner L; Sun T; Pomerantz M; Freedman M; Ross R; Regan M; Sharifi N; Figg WD; Balk S; Brown M; Taplin ME; Oh WK; Lee GS; Kantoff PW
J Clin Oncol; 2011 Jun; 29(18):2565-73. PubMed ID: 21606417
[TBL] [Abstract][Full Text] [Related]
4. Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.
Wright JL; Kwon EM; Ostrander EA; Montgomery RB; Lin DW; Vessella R; Stanford JL; Mostaghel EA
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):619-27. PubMed ID: 21266523
[TBL] [Abstract][Full Text] [Related]
5. Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.
Sissung TM; Ley AM; Strope JD; McCrea EM; Beedie S; Peer CJ; Shukla S; van Velkinburgh J; Reece K; Troutman S; Campbell T; Fernandez E; Huang P; Smith J; Thakkar N; Venzon DJ; Brenner S; Lee W; Merino M; Luo J; Jager W; Price DK; Chau CH; Figg WD
Mol Cancer Res; 2017 Aug; 15(8):1096-1105. PubMed ID: 28389619
[TBL] [Abstract][Full Text] [Related]
6. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Chew SC; Sandanaraj E; Singh O; Chen X; Tan EH; Lim WT; Lee EJ; Chowbay B
Br J Clin Pharmacol; 2012 Apr; 73(4):606-18. PubMed ID: 21995462
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.
Boivin AA; Cardinal H; Barama A; Pichette V; Hébert MJ; Roger M
Drug Metab Pharmacokinet; 2010; 25(5):508-15. PubMed ID: 20877131
[TBL] [Abstract][Full Text] [Related]
8. Extreme differences in SLCO1B3 functional polymorphisms in Roma and Hungarian populations.
Nagy A; Szalai R; Magyari L; Bene J; Toth K; Melegh B
Environ Toxicol Pharmacol; 2015 May; 39(3):1246-51. PubMed ID: 26005078
[TBL] [Abstract][Full Text] [Related]
9. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y
J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
[TBL] [Abstract][Full Text] [Related]
10. Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
de Lima LT; Bueno CT; Vivona D; Hirata RD; Hirata MH; Hungria VT; Chiattone CS; Zanichelli MA; Chauffaille Mde L; Guerra-Shinohara EM
Hematology; 2015 Apr; 20(3):137-42. PubMed ID: 25056761
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
Yamakawa Y; Hamada A; Nakashima R; Yuki M; Hirayama C; Kawaguchi T; Saito H
Ther Drug Monit; 2011 Apr; 33(2):244-50. PubMed ID: 21311410
[TBL] [Abstract][Full Text] [Related]
12. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
Schwarz UI; Meyer zu Schwabedissen HE; Tirona RG; Suzuki A; Leake BF; Mokrab Y; Mizuguchi K; Ho RH; Kim RB
Pharmacogenet Genomics; 2011 Mar; 21(3):103-14. PubMed ID: 21278621
[TBL] [Abstract][Full Text] [Related]
14. Influence of SLCO1B3 gene polymorphism on the pharmacokinetics of digoxin in terminal renal failure.
Tsujimoto M; Dan Y; Hirata S; Ohtani H; Sawada Y
Drug Metab Pharmacokinet; 2008; 23(6):406-11. PubMed ID: 19122334
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the study of organic anion transporting polypeptide 1B3].
Li X; Li Y
Yao Xue Xue Bao; 2011 Nov; 46(11):1279-85. PubMed ID: 22260016
[TBL] [Abstract][Full Text] [Related]
16. OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids.
Malagnino V; Hussner J; Issa A; Midzic A; Meyer Zu Schwabedissen HE
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G751-G762. PubMed ID: 31509437
[TBL] [Abstract][Full Text] [Related]
17. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
Miura M; Satoh S; Inoue K; Kagaya H; Saito M; Inoue T; Suzuki T; Habuchi T
Eur J Clin Pharmacol; 2007 Dec; 63(12):1161-9. PubMed ID: 17906856
[TBL] [Abstract][Full Text] [Related]
18. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
Geng F; Jiao Z; Dao YJ; Qiu XY; Ding JJ; Shi XJ; Li ZD; Zhong MK
Clin Chim Acta; 2012 Apr; 413(7-8):683-90. PubMed ID: 22227166
[TBL] [Abstract][Full Text] [Related]
19. SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.
Rajanala SH; Plym A; Vaselkiv JB; Ebot EM; Matsoukas K; Lin Z; Chakraborty G; Markt SC; Penney KL; Lee GM; Mucci LA; Kantoff PW; Stopsack KH
Carcinogenesis; 2024 Feb; 45(1-2):35-44. PubMed ID: 37856781
[TBL] [Abstract][Full Text] [Related]
20. Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p.
Barbier RH; McCrea EM; Lee KY; Strope JD; Risdon EN; Price DK; Chau CH; Figg WD
Sci Rep; 2021 May; 11(1):10765. PubMed ID: 34031488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
